TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
TriptoBIO has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in September 2023.
TriptoBIO's investors include BioInnovation Institute.
TriptoBIO is headquartered in Copenhagen, Denmark.
TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
TriptoBIO is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TriptoBIO — Funding & Investors." VCBacked, September 4, 2023, https://www.vcbacked.co/company/triptobio. Accessed August 14, 2026.
VCBacked. (2023). TriptoBIO — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/triptobio
{{cite web |title=TriptoBIO — Funding & Investors |url=https://www.vcbacked.co/company/triptobio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated